Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy.
Autorzy:
Yu Y; Department of Ophthalmology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. Hu YX; Department of Ophthalmology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. Lu MX; Department of Ophthalmology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. Ouyang ZL; Department of Ophthalmology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China. Xu MT; Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. ZhaoLY; Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. . Wang M; Department of Ophthalmology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. .
Pokaż więcej
Źródło:
Ophthalmology and therapy [Ophthalmol Ther] 2024 Apr; Vol. 13 (4), pp. 1015-1024. Date of Electronic Publication: 2024 Feb 20.
Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.
Autorzy:
Ling Q; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Huang ST; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Yu TH; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Liu HL; West China School of Medicine, Sichuan University, Chengdu, China. ZhaoLY; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Chen XL; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Liu K; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Chen XZ; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Yang K; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Hu JK; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China. .; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. . Zhang WH; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China. .; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. .
Phylogeography of cultivated and wild ophiopogon japonicus based on chloroplast DNA: exploration of the origin and sustainable cultivation.
Autorzy:
ZhaoLY; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Liu YL; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Shen Y; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Zhang QY; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Liu S; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Ren QR; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Qin LP; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. . Sun YQ; College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. .
Pokaż więcej
Źródło:
BMC plant biology [BMC Plant Biol] 2023 May 08; Vol. 23 (1), pp. 242. Date of Electronic Publication: 2023 May 08.
Is No. 12a Lymph Node Dissection Compliance Necessary in Patients Who Undergo D2 Gastrectomy for Gastric Adenocarcinomas? A Population-Based Retrospective Propensity Score Matching Study.
Autorzy:
Zhu YF; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Liu K; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Zhang WH; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Song XH; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Peng BQ; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Liao XL; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Chen XL; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. ZhaoLY; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Yang K; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China. Hu JK; Gastric Cancer Centre, Department of General Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jan 25; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 25.
AP-2δ Is the Most Relevant Target of AP-2 Family-Focused Cancer Therapy and Affects Genome Organization.
Autorzy:
Kołat D; Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland. ZhaoLY; Gastric Cancer Center and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Innovation Centre for Biotherapy, Chengdu 610041, China. Kciuk M; Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland.; Doctoral School of Exact and Natural Sciences, University of Lodz, 90-237 Lodz, Poland. Płuciennik E; Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland. Kałuzińska-Kołat Ż; Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Dec 19; Vol. 11 (24). Date of Electronic Publication: 2022 Dec 19.
[The value of synthetic MRI in differential diagnosis of benign and malignant breast lesions].
Autorzy:
Che SN; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Li J; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Xue M; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Song Y; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. ZhaoLY; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Guo N; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Tian Y; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Xie LZ; GE MR Research China, Beijing 100176, China. Zhao XM; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Zhou CW; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion.
Autorzy:
Li X; Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, PR China. . Chen J; Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, PR China. Chen YJ; Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, PR China. Qiao YD; Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, PR China. ZhaoLY; Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, PR China. Jiang N; Department of Transplantation, the Second Affiliated Hospital of Southern University of Science and Technology and the Third People's Hospital of Shenzhen, 29th Bulan Road, Shenzhen, 510623, PR China. Wu XY; Department of Medical Oncology and Guangdong Key laboratory of Liver Disease Research, the Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, PR China. . Xing YF; Department of Nephrology, The Third Affiliated Hospital of Guangzhou Medical University, 63 Duobao Road, Guangzhou, 510150, PR China. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2021 Feb 26; Vol. 4 (1), pp. 252. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
Autorzy:
Liu MM; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Chen ZH; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. ZhaoLY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Zhao JY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Rong DL; Department of Radiology and Guangdong Key Laboratory of Liver Disease, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Ma XK; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Ruan DY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Lin JX; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Qi JJ; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Hu PS; Department of Medical Oncology of Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Wen JY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Chen J; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Lin Q; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Wu XY; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Wei L; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Dong M; Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Pokaż więcej
Źródło:
Oncology research and treatment [Oncol Res Treat] 2021; Vol. 44 (9), pp. 450-468. Date of Electronic Publication: 2021 Aug 11.
Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China.
Autorzy:
Song XH; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. Zhang WH; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. Kai-Liu; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. Chen XL; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. ZhaoLY; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. Chen XZ; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. Kun-Yang; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. Zhou ZG; Department of Gastrointestinal Surgery and Laboratory of Digestive Surgery, Institute of Digestive Surgery and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. Hu JK; Department of Gastrointestinal Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan, China. .
In-tube solid-phase microextraction with a hybrid monolithic column for the preconcentration of ultra-trace metals prior to simultaneous determination by ICP-MS.
Autorzy:
Fei JJ; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry & Chemical Engineering and Center of Materials Analysis, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China. ZhaoLY; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry & Chemical Engineering and Center of Materials Analysis, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China. Wu XH; Technical Center for Industrial Product and Raw Material Inspection and Testing, Shanghai Customs, Shanghai, 200135, China. Cui XB; College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Min H; Technical Center for Industrial Product and Raw Material Inspection and Testing, Shanghai Customs, Shanghai, 200135, China. Lian HZ; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry & Chemical Engineering and Center of Materials Analysis, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China. . Chen YJ; State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry & Chemical Engineering and Center of Materials Analysis, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China. .
Pokaż więcej
Źródło:
Mikrochimica acta [Mikrochim Acta] 2020 May 28; Vol. 187 (6), pp. 356. Date of Electronic Publication: 2020 May 28.
Mechanochemical Synthesis of Porous Carbons and Their Applications in Catalysis.
Autorzy:
ZhaoLY; State Key Laboratory of Fine Chemicals Liaoning Key Laboratory for Catalytic Conversion of Carbon Resources School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, P. R. China. Dong XL; State Key Laboratory of Fine Chemicals Liaoning Key Laboratory for Catalytic Conversion of Carbon Resources School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, P. R. China. Lu AH; State Key Laboratory of Fine Chemicals Liaoning Key Laboratory for Catalytic Conversion of Carbon Resources School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, P. R. China.
Pokaż więcej
Źródło:
ChemPlusChem [Chempluschem] 2020 May; Vol. 85 (5), pp. 866-875.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
A Mechanochemical-Assisted Synthesis of Boron, Nitrogen Co-Doped Porous Carbons as Metal-Free Catalysts.
Autorzy:
ZhaoLY; State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian City, Liaoning Province, 116024, P.R. China. Dong XL; State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian City, Liaoning Province, 116024, P.R. China. Chen JY; State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian City, Liaoning Province, 116024, P.R. China. Lu AH; State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian City, Liaoning Province, 116024, P.R. China.
MicroRNA-1269 promotes cell proliferation via the AKT signaling pathway by targeting RASSF9 in human gastric cancer.
Autorzy:
Liu WL; 1Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi China. Wang HX; 2Mammary Department, Shaanxi Provincial Tumor Hospital, Xi'an, 710061 Shaanxi China. Shi CX; 3Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi China. Shi FY; 3Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi China. ZhaoLY; 4Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi China. Zhao W; 3Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi China. Wang GH; 3Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi China.
Pokaż więcej
Źródło:
Cancer cell international [Cancer Cell Int] 2019 Nov 21; Vol. 19, pp. 308. Date of Electronic Publication: 2019 Nov 21 (Print Publication: 2019).
MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma.
Autorzy:
Zhang JF; 1Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, 710021 Shaanxi People's Republic of China.; 2Department of Human Anatomy, Xi'an Medical University, Xi'an, 710021 Shaanxi People's Republic of China. Zhang JS; 3Department of Human Anatomy, Histology and Embryology, Xi'an Jiaotong University Health Science Center, Xi'an, 710061 Shaanxi People's Republic of China. Zhao ZH; 2Department of Human Anatomy, Xi'an Medical University, Xi'an, 710021 Shaanxi People's Republic of China. Yang PB; 3Department of Human Anatomy, Histology and Embryology, Xi'an Jiaotong University Health Science Center, Xi'an, 710061 Shaanxi People's Republic of China. Ji SF; 3Department of Human Anatomy, Histology and Embryology, Xi'an Jiaotong University Health Science Center, Xi'an, 710061 Shaanxi People's Republic of China. Li N; 4Department of Neuropathology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi People's Republic of China. Shi QD; 5The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi People's Republic of China. Tan J; 5The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061 Shaanxi People's Republic of China. Xu X; 1Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, 710021 Shaanxi People's Republic of China.; 2Department of Human Anatomy, Xi'an Medical University, Xi'an, 710021 Shaanxi People's Republic of China. Xu CB; 1Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, 710021 Shaanxi People's Republic of China. ZhaoLY; 6Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061 People's Republic of China.
Pokaż więcej
Źródło:
Cancer cell international [Cancer Cell Int] 2018 Dec 03; Vol. 18, pp. 195. Date of Electronic Publication: 2018 Dec 03 (Print Publication: 2018).
Recent progress in drug delivery of pluronic P123: pharmaceutical perspectives.
Autorzy:
ZhaoLY; a Department of Pharmacy , Hebei North University , Zhangjiakou , PR China. Zhang WM; a Department of Pharmacy , Hebei North University , Zhangjiakou , PR China.
Pokaż więcej
Źródło:
Journal of drug targeting [J Drug Target] 2017 Jul; Vol. 25 (6), pp. 471-484. Date of Electronic Publication: 2017 Feb 20.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
